Cooper R, Wang J, Yang H
Biomacromolecules. 2024; 25(9):5928-5937.
PMID: 39189328
PMC: 11443594.
DOI: 10.1021/acs.biomac.4c00597.
Ge L, Su N, Fan W, Yuan S
Int J Gen Med. 2024; 17:447-456.
PMID: 38333017
PMC: 10849908.
DOI: 10.2147/IJGM.S446617.
Li S, Wang X, Dou Z, Zhang J, Jia J
BMC Ophthalmol. 2023; 23(1):463.
PMID: 37974090
PMC: 10655399.
DOI: 10.1186/s12886-023-03209-4.
Li C, Zhang B, Tan X, Jia Y, Guo L, Wang C
BMC Ophthalmol. 2023; 23(1):196.
PMID: 37142972
PMC: 10158219.
DOI: 10.1186/s12886-023-02913-5.
Confalonieri F, Josifovska N, Boix-Lemonche G, Stene-Johansen I, Bragadottir R, Lumi X
Int J Mol Sci. 2023; 24(4).
PMID: 36834754
PMC: 9961686.
DOI: 10.3390/ijms24043342.
Study on the efficacy and safety of foldable capsular vitreous body in the severe retinal detachment eyes.
Ma S, Zhao S, Zhang C, Tang X, Zhou W
BMC Ophthalmol. 2022; 22(1):491.
PMID: 36522622
PMC: 9756693.
DOI: 10.1186/s12886-022-02729-9.
Vitreous Substitutes as Drug Release Systems.
Schulz A, Szurman P
Transl Vis Sci Technol. 2022; 11(9):14.
PMID: 36125790
PMC: 9508686.
DOI: 10.1167/tvst.11.9.14.
Vitreous function and intervention of it with vitrectomy and other modalities.
Zong Y, Gao Q, Hui Y
Int J Ophthalmol. 2022; 15(6):857-867.
PMID: 35814889
PMC: 9203484.
DOI: 10.18240/ijo.2022.06.02.
Outcomes of a Foldable Capsular Vitreous Body Implantation: A Retrospective Study.
Xu X, Ge H, Li J, Shang W, Ji Y, Yang W
Dis Markers. 2022; 2021:6575195.
PMID: 34987675
PMC: 8720596.
DOI: 10.1155/2021/6575195.
Evaluation of the long-term effect of foldable capsular vitreous bodies in severe ocular rupture.
Deng J, Song H, Zhou R, Chen T, Wang J, Zhu Z
Int J Ophthalmol. 2021; 14(12):1935-1940.
PMID: 34926211
PMC: 8640779.
DOI: 10.18240/ijo.2021.12.19.
Vitreous function and intervention of it with vitrectomy and other modalities.
Zong Y, Gao Q, Hui Y
Int J Ophthalmol. 2021; 14(10):1610-1618.
PMID: 34667740
PMC: 8481995.
DOI: 10.18240/ijo.2021.10.20.
Peptidomimetics Therapeutics for Retinal Disease.
Parsons D, Lee S, Sun Y, Velez G, Bassuk A, Smith M
Biomolecules. 2021; 11(3).
PMID: 33668179
PMC: 7995992.
DOI: 10.3390/biom11030339.
Substitutes and Colloidal System for Vitreous Replacement and Drug Delivery: Recent Progress and Future Prospective.
Thacker M, Tseng C, Lin F
Polymers (Basel). 2021; 13(1).
PMID: 33396863
PMC: 7796247.
DOI: 10.3390/polym13010121.
Effect on rabbits' intraocular structure by cross-linked hyaluronic formations as vitreous substitute.
Gong Y, Chen K, Wu Y, Guo X, Zhang T
Int J Ophthalmol. 2020; 13(10):1531-1537.
PMID: 33078101
PMC: 7511374.
DOI: 10.18240/ijo.2020.10.04.
Study on the effectiveness and safety of Foldable Capsular Vitreous Body implantation.
Zhang X, Tian X, Zhang B, Guo L, Li X, Jia Y
BMC Ophthalmol. 2019; 19(1):260.
PMID: 31852464
PMC: 6921415.
DOI: 10.1186/s12886-019-1268-x.
Ex vivo biophysical characterization of a hydrogel-based artificial vitreous substitute.
Januschowski K, Schnichels S, Hurst J, Hohenadl C, Reither C, Rickmann A
PLoS One. 2019; 14(1):e0209217.
PMID: 30615640
PMC: 6322733.
DOI: 10.1371/journal.pone.0209217.
Adenosine for postoperative analgesia: A systematic review and meta-analysis.
Jin X, Mi W
PLoS One. 2017; 12(3):e0173518.
PMID: 28333936
PMC: 5363816.
DOI: 10.1371/journal.pone.0173518.
Intraocular silicone implant to treat chronic ocular hypotony-preliminary feasibility data.
Bayoudh W, Frentz M, Carstesen D, Dittrich B, Reismann C, Schrage N
Graefes Arch Clin Exp Ophthalmol. 2016; 254(11):2131-2139.
PMID: 27165132
DOI: 10.1007/s00417-016-3364-4.